Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20290-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- ALG3 antibody
- Antibody type
- Polyclonal
- Description
- ALG3 antibody (Cat. #20290-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Integrating TCGA and Single-Cell Sequencing Data for Hepatocellular Carcinoma: A Novel Glycosylation (GLY)/Tumor Microenvironment (TME) Classifier to Predict Prognosis and Immunotherapy Response.
Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
Expression of ALG3 in Hepatocellular Carcinoma and Its Clinical Implication.
ALG3 Promotes Peritoneal Metastasis of Ovarian Cancer through Increasing Interaction of α1,3-mannosylated uPAR and ADAM8.
A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma.
ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.
Wu Y, Chen J, Zhu R, Huang G, Zeng J, Yu H, He Z, Han C
Metabolites 2024 Jan 13;14(1)
Metabolites 2024 Jan 13;14(1)
Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
Yuan Y, Xie B, Guo D, Liu C, Jiang G, Lai G, Zhang Y, Hu X, Wu Z, Zheng R, Huang L
Heliyon 2023 Jul;9(7):e18065
Heliyon 2023 Jul;9(7):e18065
Expression of ALG3 in Hepatocellular Carcinoma and Its Clinical Implication.
Zhao Z, Zheng Z, Huang J, Wang J, Peng T, Lin Y, Jian Z
Frontiers in molecular biosciences 2022;9:816102
Frontiers in molecular biosciences 2022;9:816102
ALG3 Promotes Peritoneal Metastasis of Ovarian Cancer through Increasing Interaction of α1,3-mannosylated uPAR and ADAM8.
Cui X, Pei X, Wang H, Feng P, Qin H, Liu S, Yan Q, Liu J
Cells 2022 Oct 6;11(19)
Cells 2022 Oct 6;11(19)
A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma.
Liang JX, Chen Q, Gao W, Chen D, Qian XY, Bi JQ, Lin XC, Han BB, Liu JS
BMC bioinformatics 2022 Dec 27;23(1):562
BMC bioinformatics 2022 Dec 27;23(1):562
ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.
Sun X, He Z, Guo L, Wang C, Lin C, Ye L, Wang X, Li Y, Yang M, Liu S, Hua X, Wen W, Lin C, Long Z, Zhang W, Li H, Jian Y, Zhu Z, Wu X, Lin H
Journal of experimental & clinical cancer research : CR 2021 Apr 30;40(1):149
Journal of experimental & clinical cancer research : CR 2021 Apr 30;40(1):149
No comments: Submit comment
No validations: Submit validation data